Global Markets Direct's, 'Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/23241/Bacterial-Infections-%E2%80%93-Pipeline-Review,-H1-2013/
2. DescriptionDescription
Reports Cornerwww.reportscorner.com
Global Markets Direct's, 'Bacterial Infections - Pipeline Review, H1
2013', provides an overview of the indication's therapeutic
pipeline. This report provides information on the therapeutic
development for Bacterial Infections, complete with latest
updates, and special features on late-stage and discontinued
projects.
3. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Global Markets Direct's, 'Bacterial Infections - Pipeline Review, H1
2013', provides an overview of the indication's therapeutic
pipeline. This report provides information on the therapeutic
development for Bacterial Infections, complete with latest
updates, and special features on late-stage and discontinued
projects. It also reviews key players involved in the therapeutic
development for Bacterial Infections. Bacterial Infections -
Pipeline Review, Half Year is built using data and information
sourced from Global Markets Direct's proprietary databases,
Company/University websites, SEC filings, investor presentations
and featured press releases from company/university sites and
industry-specific third party sources, put together by Global
Markets Direct's team.
Note*: Certain sections in the report may be removed or altered
based on the availability and relevance of data for the indicated
disease.
4. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Scope
- A snapshot of the global therapeutic scenario for Bacterial
Infections.
- A review of the Bacterial Infections products under development
by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development
ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
combined therapeutics.
- Coverage of the Bacterial Infections pipeline on the basis of
route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
5. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Reasons to buy
- Identify and understand important and diverse types of
therapeutics under development for Bacterial Infections.
- Identify emerging players with potentially strong product
portfolio and design effective counter-strategies to gain
competitive advantage.
- Plan mergers and acquisitions effectively by identifying players
of the most promising pipeline.
- Devise corrective measures for pipeline projects by
understanding Bacterial Infections pipeline depth and focus of
Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects
to enhance and expand business potential and scope.
6. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
- Modify the therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove them from
pipeline.
7. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
Table of Contents
Table of Contents 2
Introduction 12
Bacterial Infections Overview 13
Therapeutics Development 14
Bacterial Infections Therapeutics under Development by Companies 16
Bacterial Infections Therapeutics under Investigation by Universities/Institutes 39
Late Stage Products 46
Mid Clinical Stage Products 47
Early Clinical Stage Products 48
Discovery and Pre-Clinical Stage Products 49
Bacterial Infections Therapeutics – Products under Development by Companies 50
Bacterial Infections Therapeutics – Products under Investigation by Universities/Institutes 93
Companies Involved in Bacterial Infections Therapeutics Development 102
Bacterial Infections – Therapeutics Assessment 344
8. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
Drug Profiles 350
Bacterial Infections Therapeutics – Drug Profile Updates 415
Bacterial Infections Therapeutics – Discontinued Products 444
Bacterial Infections Therapeutics - Dormant Products 453
Bacterial Infections – Product Development Milestones 481
Appendix 488
9. For more informationFor more information
Reports Cornerwww.reportscorner.com
For more information please visit our website
https://www.reportscorner.com/reports/23241/Bacterial-Infections-%E2%80%93-
Pipeline-Review,-H1-2013/
